Access Statistics for Bruno Versaevel

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 0 2 2 7 18
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 0 0 2 5 33
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 0 1 1 2 14
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 0 0 0 6 19
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 0 5 7 10 25
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 0 0 3 10 19
Approche économique des accords de report d’entrée dans l’industrie pharmaceutique 0 0 0 0 2 2 3 4
Better than a compromise, a third way: Using patent pooling to accelerate access to vaccines and treatments against Covid-19 0 0 0 1 3 5 15 20
Better than a compromise, a third way: patent pool to accelerate access to vaccines and treatments against Covid-19 0 0 0 1 0 3 8 15
Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain? 0 0 0 13 3 9 20 41
Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain? 0 0 0 0 2 2 8 13
Caveat Preemptor: Coordination Failure and Success in a Duopoly Investment Game 0 0 0 0 2 3 5 42
Conflict and Cooperation on R&D Markets 0 0 0 90 4 4 10 294
Coordination and Cooperation in Investment Timing with Externalities? 0 0 0 17 3 4 14 116
Covid-19: Should intellectual property rights be challenged? 0 0 0 8 2 3 5 79
Dynamic competition and intellectual property rights in a model of product development 0 0 1 1 2 3 10 45
Dynamic competition and intellectual property rights in a model of product development 0 0 0 0 1 1 1 19
Dynamique des marchés et ajustement de la protection Intellectuelle 0 0 0 0 0 0 4 18
Dynamique des marchés et ajustement de la protection intellectuelle 0 0 0 0 0 2 2 11
Développements récents de l'approche économique des sanctions dans le cas des cartels 0 0 0 0 0 0 1 10
Développements récents de l'approche économique des sanctions dans le cas des cartels 0 0 0 0 1 1 3 21
Développements récents de l'approche économique des sanctions dans le cas des cartels 0 0 0 0 1 1 5 33
From Private to Public Common Agency 0 0 0 0 0 2 10 51
From private to public common agency 0 0 0 0 3 3 9 18
Horizontal R&D Cooperation and Spillovers: Evidence from France 0 0 0 0 3 4 6 14
Implications des licences FRAND pour la concurrence: un regard économique 0 0 0 0 1 2 5 21
Implications des licences FRAND pour la concurrence: un regard économique 0 0 0 0 0 0 3 12
Innovation and Imitation Incentives in Dynamic Duopoly 0 0 0 0 2 3 11 42
Innovation and Imitation Incentives in Dynamic Duopoly 0 0 0 0 0 4 13 44
Innovation and imitation incentives in dynamic duopoly 0 0 0 49 2 5 11 106
Investment Timing and Vertical Relationships 0 0 0 37 2 2 8 98
Investment timing and vertical relationships 0 0 0 0 2 3 7 15
Market Share, R&D Cooperation, and EU Competition Policy 0 0 0 3 0 2 10 38
Market shares, R&D agreements, and the EU block exemption 0 0 0 0 0 0 4 36
Market shares, R&D agreements, and the EU block exemption 0 0 0 0 2 7 13 28
Mise en oeuvre de la collusion et détection: approches actives et passives 0 0 0 0 4 4 6 9
Mise en oeuvre de la collusion et détection: approches actives et passives 0 0 0 0 2 3 5 19
On the Optimal Timing of Innovation and Imitation 0 0 0 0 2 2 5 21
On the Timing of Vertical Relationships 0 0 0 45 1 2 10 90
On the tacit collusion equilibria of a dynamic duopoly investment game 0 0 0 0 5 8 9 19
On the timing of innovation and imitation 0 0 0 28 0 2 8 51
On the timing of innovation and imitation in dynamic duopoly 0 0 0 0 1 2 4 14
On the timing of vertical relationships 0 0 0 36 4 4 11 81
One Lab, Two Firms, Many Possibilities: on R&D outsourcing in the biopharmaceutical industry 0 0 0 0 1 4 13 42
One Lab, Two Firms, Many Possibilities: on R&D outsourcing in the biopharmaceutical industry 0 0 0 28 4 5 14 73
One lab, two firms, many Possibilities: On R&D outsourcing in the biopharmaceutical industry 0 0 0 0 3 6 10 21
One lab, two firms, many Possibilities: On R&D outsourcing in the biopharmaceutical industry 0 0 0 0 1 6 14 27
Optimal Collusion with Limited Liability 0 0 0 0 0 1 7 42
Optimal Collusion with Limited Liability and Policy Implications 0 0 0 52 0 0 9 128
Optimal Collusion with Limited Liability and Policy Implications 0 0 0 0 0 3 6 28
Optimal collusion with limited liability 0 0 0 40 5 6 12 101
Patent Pools and Dynamic R&D Incentives 0 0 0 0 1 2 8 30
Patent Pools and R&D Dynamics 0 0 0 0 2 3 8 32
Patent pools and dynamic R&D incentives 0 0 0 0 3 4 8 50
Pool patents to get COVID vaccines and drugs to all 0 0 0 7 2 3 4 37
Quel rôle pour la part de marché quand le droit de la concurrence porte son regard sur la coopération et l'innovation 0 0 0 0 0 0 3 14
Quel rôle pour un critère de part de marché dans la réglementation de la coopération en recherche et développement ? 0 0 0 0 2 3 5 13
Quelles spécificités des accords de distribution en ligne ? 0 0 0 0 4 4 6 14
R&D Delegation in a Duopoly with Spillovers 0 0 0 0 1 1 9 10
R&D Delegation in a Duopoly with Spillovers 0 0 0 0 1 3 12 24
Tacit Collusion in Investment Timing 0 0 0 0 2 2 2 18
Testing Optimal Punishment Mechanisms under Price Regulation: the Case of the Retail Market for Gasoline 0 0 0 32 1 2 6 138
Testing Optimal Punishment Mechanisms under Price Regulation: the Case of the Retail Market for Gasoline 0 0 0 47 6 10 18 268
Testing Optimal Punishment Mechanisms under Price Regulation: the Case of the Retail Market for Gasoline 0 0 0 47 0 1 10 254
Timing Vertical Relationships 0 0 0 0 1 2 4 25
Timing Vertical Relationships 0 0 0 0 4 5 8 33
Timing Vertical Relationships 0 0 0 0 3 3 6 26
Timing Vertical Relationships 0 0 0 53 1 1 7 79
Timing Vertical Relationships 0 0 0 0 1 1 5 21
Timing Vertical Relationships 0 0 0 0 2 2 6 30
When should a winner take all, or pay some? Innovation and imitation incentives in a dynamic duopoly 0 0 0 77 4 5 15 68
Total Working Papers 0 0 1 712 125 210 557 3,382
3 registered items for which data could not be found

Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 2 2 4 17 54
Caveat preemptor: Coordination failure and success in a duopoly investment game 0 0 0 11 1 2 9 116
Co-ordination costs and vertical integration in production franchise networks: a common agency model 0 0 0 46 2 4 8 144
Dynamic competition and intellectual property rights in a model of product development 0 0 0 7 3 6 16 93
From private to public common agency 0 0 0 29 0 6 11 129
Horizontal R and D cooperation and spillovers: evidence from France 0 0 0 5 5 6 11 53
Investment timing and vertical relationships 0 0 1 17 4 8 15 61
La spéculation sur le marché des actions: un phénomène monétaire ? 0 0 0 1 1 1 2 20
Market shares, R&D agreements, and the EU block exemption 0 1 1 12 2 6 13 94
Mieux qu’un compromis, une troisième voie: le panier de brevets pour accélérer l’accès aux vaccins et traitements contre la COVID-19 0 0 0 5 4 7 12 23
On the tacit collusion equilibria of a dynamic duopoly investment game 0 1 1 13 3 5 8 85
One lab, two firms, many possibilities: On R&D outsourcing in the biopharmaceutical industry 0 0 0 2 4 9 22 63
Optimal collusion with limited liability 0 0 0 9 2 4 14 78
Patent pools and dynamic R&D incentives 0 0 0 27 3 4 18 132
Pool patents to get COVID vaccines and drugs to all 0 0 0 3 4 5 10 21
R&D Delegation in a Duopoly with Spillovers 0 0 1 26 1 3 8 116
Total Journal Articles 0 2 4 215 41 80 194 1,282

logo

LogEc Home

Top Working Papers
Top Journal Articles
Top Books
Top Chapters
Top Software Items

Top Authors

Top Working Paper series and Journals

About LogEc

Authors with papers registered in the RePEc Author Service.

Register yourself as an author or register more papers in the RePEc Author Service.

Authors with no registered papers

RePEc
LogEc provides access and usage statistics for services based on the RePEc data set.

Örebro UniversityLogEc is hosted by the Örebro University School of Business.

Questions or comments? Please see our explanation of how the statistics are collected or e-mail

Since October 2025, abstract view statistics are potentially heavily influenced by traffic from AI bots and tools that we could not eliminate despite our best efforts.

Statistics updated 2026-05-06